VistaGen Therapeutics
VTGN
VTGN
106 hedge funds and large institutions have $269M invested in VistaGen Therapeutics in 2021 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 39 increasing their positions, 29 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
25% less capital invested
Capital invested by funds: $360M → $269M (-$91.2M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
93% less call options, than puts
Call options by funds: $73K | Put options by funds: $1.04M
Holders
106
Holding in Top 10
1
Calls
$73K
Puts
$1.04M
Top Buyers
| 1 | +$6.52M | |
| 2 | +$3.9M | |
| 3 | +$2.93M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$1.45M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$1.04M |
Top Sellers
| 1 | -$2.31M | |
| 2 | -$2.18M | |
| 3 | -$1.74M | |
| 4 |
Two Sigma Investments
New York
|
-$1.26M |
| 5 |
Millennium Management
New York
|
-$862K |